Impact of pre-existing T cell immunity to SARS-CoV-2 in uninfected individuals with COVID-19 mortality in different countries
View ORCID ProfileGennadi V. Glinsky
doi: https://doi.org/10.1101/2020.10.03.20206151
Gennadi V. Glinsky
1Institute of Engineering in Medicine, University of California, San Diego, 9500 Gilman Dr. MC 0435, La Jolla, CA 92093-0435, USA

Data Availability
All data referred to in the manuscript and note are available.
Posted October 12, 2020.
Impact of pre-existing T cell immunity to SARS-CoV-2 in uninfected individuals with COVID-19 mortality in different countries
Gennadi V. Glinsky
medRxiv 2020.10.03.20206151; doi: https://doi.org/10.1101/2020.10.03.20206151
Subject Area
Subject Areas
- Addiction Medicine (164)
- Allergy and Immunology (416)
- Anesthesia (92)
- Cardiovascular Medicine (867)
- Dermatology (98)
- Emergency Medicine (251)
- Epidemiology (8589)
- Gastroenterology (390)
- Genetic and Genomic Medicine (1772)
- Geriatric Medicine (169)
- Health Economics (375)
- Health Informatics (1252)
- Health Policy (625)
- Hematology (197)
- HIV/AIDS (380)
- Medical Education (193)
- Medical Ethics (51)
- Nephrology (214)
- Neurology (1692)
- Nursing (97)
- Nutrition (252)
- Oncology (933)
- Ophthalmology (265)
- Orthopedics (104)
- Otolaryngology (172)
- Pain Medicine (115)
- Palliative Medicine (40)
- Pathology (255)
- Pediatrics (539)
- Primary Care Research (210)
- Public and Global Health (3871)
- Radiology and Imaging (627)
- Respiratory Medicine (525)
- Rheumatology (208)
- Sports Medicine (158)
- Surgery (191)
- Toxicology (36)
- Transplantation (101)
- Urology (76)